Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2021-04-22
2031-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Functional Substrate Mapping of Ventricular Tachycardia
NCT05708131
DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
NCT04265040
Brain Perfusion and Hemodynamic Stability in Patients Undergoing Radiofrequency Ablation of Ventricular Tachycardia
NCT01695551
German Ablation Quality-Register
NCT01197638
Utility of ICD Electrograms During Ventricular Tachycardia Ablation
NCT02274168
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Arm
Patients enrolled and treated with the DiamondTemp™ Ablation System
DiamondTemp™ Ablation System
A cardiac ablation will be performed using the DiamondTemp™ Ablation System.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DiamondTemp™ Ablation System
A cardiac ablation will be performed using the DiamondTemp™ Ablation System.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned procedure using commercially available DiamondTemp™ Ablation System
* Willing to comply with study requirements and give IC (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Ablation Solutions
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sunshine Coast University Hospital
Birtinya, , Australia
Fiona Stanley Hospital
Murdoch, , Australia
Universitair Ziekenhuis Brussel
Jette, , Belgium
CHRU de Tours - Hôpital Trousseau
Chambray-lès-Tours, , France
Capio - Clinique du Tonkin
Villeurbanne, , France
Herz- und Diabeteszentrum NRW - Ruhr-Universität Bochum
Bad Oeynhausen, , Germany
Universitäres Herzzentrum
Hamburg, , Germany
Saint Vincenz Krankenhaus Paderborn
Paderborn, , Germany
Humanitas Mater Domini
Castellanza, , Italy
Ospedale di Conegliano - S. Maria dei Battuti
Conegliano, , Italy
Ospedale dell'Angelo
Venezia, , Italy
Catharina Ziekenhuis
Eindhoven, , Netherlands
St. Antonius Ziekenhuis Nieuwegein
Nieuwegein, , Netherlands
John Paul II Upper Silesian Medical Centre
Katowice, , Poland
Hospital de Santa Marta
Lisbon, , Portugal
University Medical Centre Ljubljana
Ljubljana, , Slovenia
Hospital de la Santa Creu I Sant Pau
Barcelona, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Inselspital - Universitätsspital Bern
Bern, , Switzerland
Royal Sussex County Hospital
Brighton, , United Kingdom
University Hospitals Coventry & Warwickshire
Coventry, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Vincent Paul, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MDT20059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.